Agglutinating antibody titers to members of the family Legionellaceae in cystic fibrosis patients as a result of cross-reacting antibodies to Pseudomonas aeruginosa - PubMed (original) (raw)

Agglutinating antibody titers to members of the family Legionellaceae in cystic fibrosis patients as a result of cross-reacting antibodies to Pseudomonas aeruginosa

M T Collins et al. J Clin Microbiol. 1984 Jun.

Abstract

The objective of this study was to evaluate the prevalence and significance of antibody titers to organisms in the family Legionellaceae in 128 serum samples collected from cystic fibrosis patients at routine examinations. Antibody titers were determined for 10 antigenic types of Legionellaceae; Legionella pneumophila serogroups 1 to 6, Fluoribacter (Legionella) bozemanae, Fluoribacter (Legionella) dumoffii, Fluoribacter (Legionella) gormanii, and Tatlockia (Legionella) micdadei. The method of antibody titer determination was the microagglutination test. Elevated titers (greater than or equal to 1:64) to one or more antigens were found in 41.3% of cystic fibrosis patients but in only 9.7% of 103 normal control subjects (P less than 0.01). Titers to 8 of the 10 antigens were directly correlated with the number of Pseudomonas aeruginosa precipitating antibodies in patient sera, as determined by crossed immunoelectrophoresis (correlation coefficients, greater than or equal to 0.74). Cross-reactions between P. aeruginosa and L. pneumophila were substantiated by crossed immunoelectrophoresis of hyperimmune rabbit serum as well as patient sera against P. aeruginosa and Legionellaceae antigens. Monospecific antibody to the "common antigen" of P. aeruginosa was used to demonstrate the presence of this antigen in L. pneumophila. The presence of cross-reacting antibodies in cystic fibrosis patients chronically infected with P. aeruginosa emphasizes the need for cautious interpretation of antibody titers to members of the family Legionellaceae.

PubMed Disclaimer

Cited by

Paradoxical Pro-inflammatory Responses by Human Macrophages to an Amoebae Host-Adapted Legionella Effector.
Price C, Jones S, Mihelcic M, Santic M, Abu Kwaik Y. Price C, et al. Cell Host Microbe. 2020 Apr 8;27(4):571-584.e7. doi: 10.1016/j.chom.2020.03.003. Epub 2020 Mar 27. Cell Host Microbe. 2020. PMID: 32220647 Free PMC article.
Prevalence of antibodies in response to Legionella species, analysis of a healthy population from Jeollanam-do Province, Korea.
Lee HK, Woo MK, Ju YI, Baek SJ, Song HJ, Choi JS, Kweon SS, Jeon DY, Kang YH. Lee HK, et al. J Microbiol. 2008 Apr;46(2):160-4. doi: 10.1007/s12275-007-0181-9. Epub 2008 Jun 11. J Microbiol. 2008. PMID: 18545965
Legionella and Legionnaires' disease: 25 years of investigation.
Fields BS, Benson RF, Besser RE. Fields BS, et al. Clin Microbiol Rev. 2002 Jul;15(3):506-26. doi: 10.1128/CMR.15.3.506-526.2002. Clin Microbiol Rev. 2002. PMID: 12097254 Free PMC article. Review.
Cross-reactive antigens shared by Pseudomonas aeruginosa, Helicobacter pylori, Campylobacter jejuni, and Haemophilus influenzae may cause false-positive titers of antibody to H. pylori.
Johansen HK, Nørgaard A, Andersen LP, Jensen P, Nielsen H, Høiby N. Johansen HK, et al. Clin Diagn Lab Immunol. 1995 Mar;2(2):149-55. doi: 10.1128/cdli.2.2.149-155.1995. Clin Diagn Lab Immunol. 1995. PMID: 7697522 Free PMC article.
Laboratory diagnosis of infections caused by legionellae.
Edelstein PH. Edelstein PH. Eur J Clin Microbiol. 1987 Feb;6(1):4-10. doi: 10.1007/BF02097182. Eur J Clin Microbiol. 1987. PMID: 3552663 Review.

References

1. JAMA. 1982 Nov 12;248(18):2284-8 - PubMed
1. Acta Paediatr Scand. 1981 Sep;70(5):623-8 - PubMed
1. Infect Immun. 1983 Mar;39(3):1441-56 - PubMed
1. J Clin Microbiol. 1982 Jan;15(1):130-6 - PubMed
1. Thorax. 1984 Feb;39(2):150-4 - PubMed

Agglutinating antibody titers to members of the family Legionellaceae in cystic fibrosis patients as a result of cross-reacting antibodies to Pseudomonas aeruginosa - PubMed (original) (raw)